Baker Ellis Asset Management LLC Trims Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Baker Ellis Asset Management LLC cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 53,484 shares of the company’s stock after selling 257 shares during the quarter. Baker Ellis Asset Management LLC’s holdings in Henry Schein were worth $4,039,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in HSIC. Aurora Investment Counsel increased its stake in Henry Schein by 0.7% during the third quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock worth $1,533,000 after acquiring an additional 140 shares during the last quarter. Arizona State Retirement System increased its stake in Henry Schein by 0.4% during the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after acquiring an additional 149 shares during the last quarter. Wahed Invest LLC increased its stake in Henry Schein by 9.2% during the fourth quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock worth $168,000 after acquiring an additional 187 shares during the last quarter. Crossmark Global Holdings Inc. increased its stake in Henry Schein by 1.5% during the fourth quarter. Crossmark Global Holdings Inc. now owns 13,090 shares of the company’s stock worth $991,000 after acquiring an additional 197 shares during the last quarter. Finally, Treasurer of the State of North Carolina increased its stake in Henry Schein by 0.4% during the third quarter. Treasurer of the State of North Carolina now owns 66,473 shares of the company’s stock worth $4,936,000 after acquiring an additional 242 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Stock Up 0.0 %

NASDAQ HSIC traded up $0.01 during mid-day trading on Friday, reaching $64.10. 1,641,594 shares of the company’s stock traded hands, compared to its average volume of 985,533. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47. The company has a fifty day simple moving average of $69.91 and a 200-day simple moving average of $72.89. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a market cap of $8.21 billion, a price-to-earnings ratio of 21.66, a P/E/G ratio of 1.58 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. During the same quarter last year, the business posted $1.21 EPS. Henry Schein’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, equities research analysts expect that Henry Schein, Inc. will post 5.16 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on HSIC. UBS Group dropped their price target on Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. Jefferies Financial Group increased their target price on Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. Piper Sandler reiterated an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. Barrington Research increased their target price on Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, May 8th. Finally, JPMorgan Chase & Co. increased their target price on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research note on Wednesday, March 6th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $81.73.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.